Nicotinamide partially reverses the interleukin-1β inhibition of glucose-induced insulin release in pancreatic islets
- 31 March 1992
- journal article
- Published by Elsevier in Metabolism
- Vol. 41 (3) , 296-300
- https://doi.org/10.1016/0026-0495(92)90274-e
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of high glucose on insulin secretion by isolated rat islets and purified beta-cells and possible role of glycosylationDiabetes, 1989
- Effect of nicotinamide treatment on the residual insulin secretion in Type 1 (insulin-dependent) diabetic patientsDiabetologia, 1989
- Inhibitory Effects of Interleukin 1 on Insulin Secretion, Insulin Biosynthesis, and Oxidative Metabolism of Isolated Rat Pancreatic Islets*Endocrinology, 1987
- Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependentDiabetes, 1987
- Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD miceDiabetes, 1986
- Interleukin 1 inhibits insulin secretion from isolated perifused rat isletsDiabetes, 1986
- Affinity-purified human Interleukin I is cytotoxic to isolated islets of LangerhansDiabetologia, 1986
- Mechanisms of streptozotocin- and alloxan-induced damage in rat B cellsDiabetologia, 1984
- Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) miceDiabetes, 1982
- Pyridine Nucleotide Depletion in Pancreatic Islets Associated with Streptozotocin-induced DiabetesDiabetes, 1972